Yehuda Handelsman, MD, FNLA, FACP, MACE is an endocrinologist in private practice and Medical Director & Principal Investigator of the Metabolic Institute of America. He is a nationally and internationally-recognized authority on Diabetes and its comprehensive approach to management, obesity, Dyslipidemia, HTN, insulin resistance, pre-diabetes, and the prevention of cardiovascular disease. He is a leader in understanding the bodyโs metabolic and energy systems and the kidney role in Glucose homeostasis.
A Master of the American College of Endocrinology, Fellow of the American College of Physicians and The National Lipid Association He is also a Trustee of the American College of Endocrinology, President of the Pacific Lipid Association, Member Board of Directors, American Association for Preventive Cardiology. Chair of the AACE Diabetes and Lipid Scientific Committees and a member the AACE Obesity Scientific Committee. Past president of the American College of Endocrinology (ACE) & of the American Association of Clinical Endocrinologists (AACE) He is chair Founder & program director of the acclaimed annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease and the Heart in Diabetes- initiative and Medical Congress; Chair & Founder the International Lipid Forum, an Associate Editor of the Journal of Diabetes, member of the editorial board of several journals and a frequent guest editor for publications such as the Journal of Clinical Hypertension.
Chair Task Force & Writing committee Co-Chair- AACE 2017 Lipid Guideline; Chair the AACE 2011 & 2015 Comprehensive Diabetes Guidelines; member of the AACE 2013-18 Comprehensive Diabetes Algorithms. He Chaired the consensuses on SGLT2i & DKA, Diabetes, Obesity & Cancer, Insulin Resistance Syndrome, lipodystrophy Clinical Approach and Pre-Diabetes- Clinical impact. Handelsman has been listed repeatedly in โTop Doctors of Los Angeles,โ โSouthern California Super Doctors,โ โThe Leading Physicians of the worldโ and โBest Doctors of America.โ He published near 100 Peer reviewed original research & review papers, position and consensus statements, editorials and clinical practice guidelines. His Book โClinical Management of Cardiovascular Risk in Diabetes and Obesityโ, publisher: Professional Communications, Inc. was published – 2016.
